Market Cap: $30.77B
Market Cap: $30.77B
Open
$63.62
Prev. Close
$66.20
High
$63.76
Low
$62.61
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America.
Novozymes A/S trades on the Other OTC under the ticker NVZMY, priced in USD.
Novozymes A/S has a market capitalisation of $30.77B, based on its latest share price.
NVZMY trades at 40.92 times its trailing 12-month earnings.
Over the past 52 weeks NVZMY has traded between $49.90 and $75.27.
Yes. Novozymes A/S's dividend yields 1.44% at the current share price, paying out 61% of its earnings.
Highly profitable: keeps 15.6% of revenue as net profit.
The analyst consensus rating for NVZMY is Hold.
Ester Baiget is the CEO of Novozymes A/S, which is headquartered in Lyngby.
Generated automatically from reported financial data. General information only, not financial advice.